CDXS Codexis

Codexis to Participate at Three Virtual Investment Conferences in November

Codexis to Participate at Three Virtual Investment Conferences in November

REDWOOD CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will participate at three upcoming virtual investment conferences:

  • Stifel Healthcare Conference on Monday, November 16, 2020 with presentation at 3:20 p.m. Eastern time (12:20 p.m. Pacific time)

     
  • 11th Annual Craig-Hallum Alpha Select Conference on Tuesday, November 17, 2020

     
  • Stephens Annual Investment Conference 2020 on Wednesday, November 18, 2020 with presentation at 1:00 p.m. Eastern time (10:00 a.m. Pacific time)

Live webcasts and replays of the presentations at the Stifel Healthcare Conference and Stephens Annual Investment Conference will be available on the Investors section of the company’s website, .

About Codexis, Inc.

Codexis is a leading protein engineering company that applies its proprietary CodeEvolver® technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis’ proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes. For more information, see .

Contact:

LHA Investor Relations

Jody Cain, 310-691-7100

EN
09/11/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Codexis

 PRESS RELEASE

Codexis to Report Second Quarter 2025 Financial Results on August 13

Codexis to Report Second Quarter 2025 Financial Results on August 13 REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it will report its financial results for the second quarter of 2025 on Wednesday, August 13, 2025, following the close of market. Codexis management will host a conference call and webcast at 4:30 pm Eastern Time to discuss the Company’s financial results and provide a business update. Participants may ac...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: July 22, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ResearchPool Subscriptions

Get the most out of your insights

Get in touch